Can simponi be used for rheumatoid arthritis?

Can simponi be used for rheumatoid arthritis

Simponi is approved to treat rheumatoid arthritis in adults.

Why do patients choose Simponi over other TNF inhibitors?

Patients who prefer fewer injections often select Simponi because it requires only monthly dosing compared to weekly or two-week dosing for some other TNF inhibitors. Patients who has trouble keeping consistent self-injections may find monthly dosing a practical advantage.

What side effects are patients asking about with Simponi?

Patients report common side effects such as upper respiratory infections, injection site reactions, and increased risk of serious infections. Patients also raise concerns about possible long-term risks like tuberculosis reactivation and increased cancer risk.

When does Simponi exclusivity expire?

Simponi exclusivity is expected to expire in 2025.

What alternatives exist when Simponi fails?

When Simponi fails, patients may turn to other TNF inhibitors such as Humira or Enbrel, or non-TNF biologics such as Actemra or Orencia. Patients who have trouble with self injections may turn to infusions such as Remicade.

Who makes Simponi?

Janssen Biotech makes Simponi.

When does the Simponi patent expire?

The Simponi patent expires in 2025.